Health
Start-up awarded grant to develop contrast agent for early detection of liver disease – EurekAlert
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…
ATLANTA–Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
“We have been working on this breakthrough in the lab for several years,” said Yang. “This funding will help us to…
-
Business19 hours agoWarning! These ASX 200 shares were just downgraded
-
Business12 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business12 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Business17 hours ago2 monthly payers you’ll want to own in 2025 and beyond